Shares of Absci Corporation (ABSI) gained over 6% on Wednesday morning after the company entered into a strategic collaboration with Advanced Micro Devices Inc (AMD) to enhance its AI drug discovery capabilities.
ABSI is currently trading at $3.2750, up $0.2050 or 6.6775%, on the Nasdaq. The stock opened its trading at $4.0800 after closing Tuesday at $3.0700. The stock has traded between $2.4500 and $6.7200 in the past 52-week period.
AMD will also make a $20 million investment in Absci, structured as a private investment in public equity (PIPE), underscoring the growing demand for innovative AI applications in drug discovery.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.